Free
Infographics in Anesthesiology  |   February 2019
Obstructive Sleep Apnea and Opioid-Induced Respiratory Depression: What do we know?
Author Notes
  • Vanderbilt University Medical Center
  • Brigham and Women’s Health Care/Harvard Medical School
  • Illustration by Annemarie Johnson, Vivo Visuals.
    Illustration by Annemarie Johnson, Vivo Visuals.×
  • Address correspondence to Dr. Wanderer: jonathan.p.wanderer@vanderbilt.edu.
Article Information
Infographics in Anesthesiology
Infographics in Anesthesiology   |   February 2019
Obstructive Sleep Apnea and Opioid-Induced Respiratory Depression: What do we know?
Anesthesiology 2 2019, Vol.130, A19. doi:10.1097/ALN.0000000000002621
Anesthesiology 2 2019, Vol.130, A19. doi:10.1097/ALN.0000000000002621
Complex Information for Anesthesiologists Presented Quickly and Clearly
EtCO2, end-tidal carbon dioxide; IBW, ideal body weight; MV, minute ventilation; OSA, obstructive sleep apnea; REM, rapid eye movement; RR, respiratory rate; SpO2, oxygen saturation measured by pulse oximetry; Vt, tidal volume.
Infographic created by Jonathan P. Wanderer, Vanderbilt University Medical Center, and James P. Rathmell, Brigham and Women’s Health Care/Harvard Medical School. Illustration by Annemarie Johnson, Vivo Visuals. Address correspondence to Dr. Wanderer: jonathan.p.wanderer@vanderbilt.edu.
References
Bernards, CM, Knowlton, SL, Schmidt, DF, DePaso, WJ, Lee, MK, McDonald, SB, Bains, OS Respiratory and sleep effects of remifentanil in volunteers with moderate obstructive sleep apnea. Anesthesiology 2009; 110:41–9 [Article] [PubMed]
Doufas, AG, Shafer, SL, Rashid, NHA, Kushida, CA, Capasso, R Non–steady state modeling of the ventilatory depressant effect of remifentanil in awake patients experiencing moderate-to-severe obstructive sleep apnea. Anesthesiology 2019; 130:213–26